Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and PT
Tweet Send to a FriendGet Alerts ITMN Hot Sheet
Price: $10.13 -0.1%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 23 | New: 19
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 23 | New: 19
Trade ITMN Now!
Canaccord Genuity reiterates a 'Buy' on InterMune Inc. (NASDAQ: ITMN) price target lowered from $24 to $15.
Analyst, Ritu Baral, said, "Reiterate rating, lowering target to $15 on lower, but still blockbuster, Esbriet (pirfenidone) sales prospects. Esbriet is ITMN’s drug for idiopathic pulmonary fibrosis (IPF), an orphan lung disease. We see good Esbriet EU potential (despite price concerns) and encouraging 2012 adoption, but are reducing our worldwide peak sales estimate to $2.1B from $3.6B in 2025."
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $10.08 yesterday, with a 52 week range of $9.66-$37.99.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Ritu Baral, said, "Reiterate rating, lowering target to $15 on lower, but still blockbuster, Esbriet (pirfenidone) sales prospects. Esbriet is ITMN’s drug for idiopathic pulmonary fibrosis (IPF), an orphan lung disease. We see good Esbriet EU potential (despite price concerns) and encouraging 2012 adoption, but are reducing our worldwide peak sales estimate to $2.1B from $3.6B in 2025."
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $10.08 yesterday, with a 52 week range of $9.66-$37.99.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Goldman Sachs Downgrades Thoratec (THOR) to Neutral
- Urban Outfitters (URBN) Added to Best Ideas List at Janney Capital on Solid Q1 Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
